(Q71032643)

English

Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis

scientific article published on 01 April 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

hemodialysis patient

1 reference

based on heuristic

inferred from title

Raymond L. Woosley

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

Hou ZY

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Chen CP

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Yang WC

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Lai MD

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Buchert ET

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Chung HM

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Pickle LW

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 April 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

411-417

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612385%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Co-inheritance of the polymorphic metabolism of encainide and debrisoquin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Salivary analysis for determination of dextromethorphan metabolic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Sparteine oxidation is practically abolished in quinidine-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990109-5

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71032643&oldid=2228983301"